FDA complaint filed for Bayer selenium cancer claims
In the next episode of the recent selenium saga, a formal complaint was yesterday filed with the US Food and Drug Administration (FDA) requesting that the agency seize stocks of Bayer vitamins for making misleading prostate cancer health claims.